<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Beacon NewsFlashes – June 3, 2009</title>
	<atom:link href="http://www.myelomabeacon.com/news/2009/06/03/beacon-newsflashes-%e2%80%93-june-3-2009/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.myelomabeacon.com/news/2009/06/03/beacon-newsflashes-%e2%80%93-june-3-2009/</link>
	<description>Multiple myeloma news, resources, and online forums for patients, caregivers, and others interested in multiple myeloma.</description>
	<lastBuildDate>Sat, 11 Feb 2012 02:27:53 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>By: Boris Simkovich</title>
		<link>http://www.myelomabeacon.com/news/2009/06/03/beacon-newsflashes-%e2%80%93-june-3-2009/comment-page-1/#comment-278</link>
		<dc:creator>Boris Simkovich</dc:creator>
		<pubDate>Sat, 06 Jun 2009 02:05:48 +0000</pubDate>
		<guid isPermaLink="false">http://www.myelomabeacon.com/?p=8042#comment-278</guid>
		<description>I don&#039;t know of any published data that would answer your question.  I also think the expected survival time for a case like you have mentioned depends very, very much on factors such as age and the general health of the patient.  

Since you are in Italy, perhaps you can contact Dr. Mario Boccadoro or Dr. Antonio Palumbo at the University of Turin.  They are multiple myeloma experts and opinion leaders, and they should be able to answers your questions.

Good luck!</description>
		<content:encoded><![CDATA[<p>I don&#8217;t know of any published data that would answer your question.  I also think the expected survival time for a case like you have mentioned depends very, very much on factors such as age and the general health of the patient.  </p>
<p>Since you are in Italy, perhaps you can contact Dr. Mario Boccadoro or Dr. Antonio Palumbo at the University of Turin.  They are multiple myeloma experts and opinion leaders, and they should be able to answers your questions.</p>
<p>Good luck!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: francesco bravi</title>
		<link>http://www.myelomabeacon.com/news/2009/06/03/beacon-newsflashes-%e2%80%93-june-3-2009/comment-page-1/#comment-273</link>
		<dc:creator>francesco bravi</dc:creator>
		<pubDate>Fri, 05 Jun 2009 17:36:12 +0000</pubDate>
		<guid isPermaLink="false">http://www.myelomabeacon.com/?p=8042#comment-273</guid>
		<description>What is survival&#039; time for Myeloma multiple not secerning,after two autolog trasplantantion,talidomide,dexametazone,zometa?</description>
		<content:encoded><![CDATA[<p>What is survival&#8217; time for Myeloma multiple not secerning,after two autolog trasplantantion,talidomide,dexametazone,zometa?</p>
]]></content:encoded>
	</item>
</channel>
</rss>

